DYAX CORP
DYAX CORP
Status:
Active
More informations about "Dyax Corp"
Dyax - Crunchbase Company Profile & Funding
Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet medical โฆSee details»
Dyax | Company Overview & News - Forbes
Dyax Corp. is a biopharmaceutical company, which discovers, develops and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediatedSee details»
Dyax 2025 Company Profile: Valuation, Investors, โฆ
Dyax General Information Description. Developer of biopharmaceuticals for oncology and inflammatory indications. The company offers drug discovery โฆSee details»
Dyax Corp. - Encyclopedia.com
Dyax Corp โ Foresite Capital
Dyax Corp is a biopharmaceutical company focused on Hereditary Angioedema (HAE) and other Plasma-Kallikrein-Mediated (PKM) Disorders, and licensing and funded research portfolio. Dyax develops and commercializes treatments for โฆSee details»
Shire Completes Acquisition of Dyax - Takeda
Lexington, Mass. โ January 22, 2016 โ Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it has completed its acquisition of Dyax Corp. (NASDAQ: DYAX) in an all-cash transaction โฆSee details»
Dyax Corp. - Drug pipelines, Patents, Clinical trials - Synapse
May 8, 2025 Explore Dyax Corp. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 30 news, and 63 literature, Disease Domain:Immune System Diseases, โฆSee details»
Shire Completes Acquisition of Dyax - PR Newswire
Jan 22, 2016 Dyax shareholders may receive additional value through a non-tradable contingent value right (CVR) that will pay $4.00 in cash per Dyax share upon approval of DX-2930 for โฆSee details»
DYAX CORP. · C/O The Corporation Trust Company, 1209 Orange โฆ
DYAX CORP. (LEI# 5493001O412ZK1FDTW11) is a legal entity registered with Bloomberg Finance L.P.. The address is C/O The Corporation Trust Company, 1209 Orange Street, โฆSee details»
Dyax - businessabc.net
Feb 25, 2025 Dyax's medication, ReFactoR, was the first FDA-approved therapeutic for the condition and made the company's name an industry standard. In the mid-2000s, Dyax began โฆSee details»
Dyax - Products, Competitors, Financials, Employees, Headquarters โฆ
Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. Use the CB Insights Platform to explore Dyax's full โฆSee details»
Shire to Acquire Dyax Corp, expanding and extending industry
Nov 2, 2015 Dyax is to be commended for the world class organization they have built focused on HAE.โ ... About Dyax Corp. Dyax is a biopharmaceutical company focused on the โฆSee details»
็็ฉๅถ่ฏๅ ฌๅธ๏ผDyax Corp.(DYAX) | ็พ่กไนๅฎถ
Nov 3, 2015 Dyax Corporation(NASDAQ:DYAX) ๅ็ซไบ1989ๅนด๏ผๆป้จไฝไบ้ฉฌ่จ่ฏธๅกๅทBurlington๏ผๅ จ่้ๅ124ไบบ๏ผๆฏไธๅฎถๆฒป็็็ไธ็็็จ่ฏ็ ็็ฉๅถ่ฏๅ ฌๅธ ใ ๆดๆฐ๏ผ 2016 ๅนด โฆSee details»
Shire to Acquire Dyax Corp. - Takeda
Source: Dyax Corp. Observed attack rates (versus placebo) Note: Baseline is defined as historical HAE attacks over last 3 months prior to dosing. Only includes patients with a baseline r ate of โฆSee details»
Shire to acquire Dyax, extending industry-leading HAE portfolio
Shire will acquire Dyax Corp., the publicly traded biotechnology company primarily focused on the development of plasma kallikrein (pKal) inhibitors for the treatment of HAE. Dyax has already โฆSee details»
Leadership - Woodbridge
Our Executive Leadership Team brings their vast knowledge and experience together to create a strong and agile organization. Together, they are energizing our global workforce, โฆSee details»
Minister Bains announces investment in innovative Canadian auto โฆ
Jul 9, 2019 Today, the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, announced a Government of Canada investment in Woodbridge โฆSee details»
Corporate Facts | Labcorp
HEADQUARTERS: 531 South Spring Street Burlington, North Carolina 27215: TICKER SYMBOL: LH: NUMBER OF EMPLOYEES: More than 70,000 worldwide: ANNUAL REVENUESee details»
Dynavax Files Definitive Proxy Statement and Sends Letter to โฆ
EMERYVILLE, Calif., April 17, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical โฆSee details»
OROAX Corporation | Woodbridge VA - Facebook
OROAX Corporation, Woodbridge, Virginia. 24 likes · 1 talking about this. dental InstrumentsSee details»